AZN Jul 2024 95.000 put
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 11:01AM EDT. Market open.
| Previous Close | 25.60 |
| Open | 25.60 |
| Bid | 15.90 |
| Ask | 19.40 |
| Strike | 95.00 |
| Expire Date | 2024-07-19 |
| Day's Range | 25.60 - 25.60 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
ReutersAstraZeneca aims for $80 billion in total revenue by 2030
AstraZeneca, which laid out targets as part of its investor day event, reported total revenue of $45.81 billion last year. CEO Pascal Soriot has rebuilt the company's pipeline of new drugs since taking the helm more than a decade ago, with blockbusters such as lung cancer drug Tagrisso, leukaemia drug Calquence and Farxiga for diabetes. AstraZeneca, which is facing patent expiries on some key drugs, said it would continue to invest in new technologies and platforms that will "shape the future of medicine" beyond 2030.
Business WireAstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030
CAMBRIDGE, England, May 21, 2024--Investor Day 2024
ZacksAstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
This new plant will be AstraZeneca's (AZN) first manufacturing facility for producing novel antibody drug conjugates from start to finish. It is scheduled to open in 2029.
© 2024 Yahoo. All rights reserved.